NASDAQ:RWLK ReWalk Robotics (RWLK) Stock Price, News & Analysis → Major Elon Musk Crypto Leak Revealed (From Crypto 101 Media) (Ad) Free RWLK Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range$0.64▼$1.2552-Week Range N/AVolume303,600 shsAverage Volume541,468 shsMarket Capitalization$63.04 millionP/E RatioN/ADividend YieldN/APrice Target$3.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Get ReWalk Robotics alerts: Email Address ReWalk Robotics MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside∞ Upside$3.00 Price TargetShort InterestN/ADividend StrengthN/ASustainabilityN/ANews Sentiment0.00Based on 2 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.38) to ($0.37) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.65 out of 5 starsMedical Sector864th out of 939 stocksMedical Devices Industry1st out of 1 stocks 3.5 Analyst's Opinion Consensus RatingReWalk Robotics has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $3.00, ReWalk Robotics has a forecasted upside of ∞ from its current price of $0.00.Amount of Analyst CoverageReWalk Robotics has received no research coverage in the past 90 days. Previous Next N/A Short Interest Short InterestThere is no current short interest data available for RWLK. Previous Next 0.0 Dividend Strength Dividend YieldReWalk Robotics does not currently pay a dividend.Dividend GrowthReWalk Robotics does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for RWLK. Previous Next 0.0 News and Social Media Coverage News Coverage This WeekMarketBeat has tracked 2 news articles for ReWalk Robotics this week, compared to 1 article on an average week.Search InterestOnly 1 people have searched for RWLK on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, ReWalk Robotics insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 2.10% of the stock of ReWalk Robotics is held by insiders.Percentage Held by InstitutionsOnly 3.58% of the stock of ReWalk Robotics is held by institutions. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for ReWalk Robotics are expected to grow in the coming year, from ($0.38) to ($0.37) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of ReWalk Robotics is -2.84, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of ReWalk Robotics is -2.84, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Crypto 101 MediaMajor Elon Musk Crypto Leak RevealedReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy. About ReWalk Robotics Stock (NASDAQ:RWLK)ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke in the clinical rehabilitation environment; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic. It markets and sells its products directly to third party payers; institutions, including rehabilitation centers; and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Ilit, Israel.Read More Ad DTImy top trade on these 9 tickersThis indicator is uniquely designed to spot the most significant moves in the top stocks out there (and according to our backtesting it has historically nailed these moves with a stunning 90% accuracy). Now, most folks have been saying NVDA is way overbought or overpriced. They didn’t want to “buy at the top” 6 weeks ago… Or again 4 weeks ago… or again 2 weeks ago… And it’s not their fault! That’s what all the talking heads were saying too. But the Apex Indicator would have clearly shown that these were opportunities to buy. And, sure enough, Nvidia slammed through the recommended targets again and again.Click Here for this Powerful Workshop RWLK Stock News HeadlinesMarch 27, 2024 | americanbankingnews.comReWalk Robotics (NASDAQ:RWLK) Receives New Coverage from Analysts at StockNews.comMarch 22, 2024 | globenewswire.comVA STAND Act introduced in the United States SenateMarch 28, 2024 | DTI (Ad)my top trade on these 9 tickersThis indicator is uniquely designed to spot the most significant moves in the top stocks out there (and according to our backtesting it has historically nailed these moves with a stunning 90% accuracy). Now, most folks have been saying NVDA is way overbought or overpriced. They didn’t want to “buy at the top” 6 weeks ago… Or again 4 weeks ago… or again 2 weeks ago… And it’s not their fault! That’s what all the talking heads were saying too. But the Apex Indicator would have clearly shown that these were opportunities to buy. And, sure enough, Nvidia slammed through the recommended targets again and again.March 19, 2024 | americanbankingnews.comReWalk Robotics (NASDAQ:RWLK) Research Coverage Started at StockNews.comMarch 19, 2024 | americanbankingnews.comComparing Demant A/S (OTCMKTS:WILLF) & ReWalk Robotics (NASDAQ:RWLK)March 13, 2024 | globenewswire.comLifeward Announces Reverse Share SplitMarch 8, 2024 | globenewswire.comReStore Exo-Suit Publications Demonstrate Improved Walking Outcomes Versus Conventional Stroke TherapyMarch 1, 2024 | globenewswire.comLifeward announces the Centers for Medicare & Medicaid Services (“CMS”) is deferring its final decision on the payment rate for personal exoskeletons so that more recent claims information on the current, more advanced ReWalk Personal Exoskeleton may be consideredMarch 28, 2024 | DTI (Ad)Warning: this could blow your mindBuckle up… ‘Cause this might shatter everything you’ve heard about “income trading”. In fact, it’s such an extreme diversion from what most people think of typical income trades that I call it: The Perfect Income Trade You see, most of the income techniques out there target a couple of percent. Maybe 5 - 10 percent if you’re lucky. But this new way of trading income on the world’s top stocks goes after more than 10x that kind of return. And here’s the best news of all: This trade can target an opportunity like that every week. Every single week. Meaning an investor has the chance to “stack up” these more aggressive income trades over and over. If that sounds interesting…February 27, 2024 | globenewswire.comLifeward Reports Fourth Quarter and Full Year 2023 Financial ResultsFebruary 20, 2024 | globenewswire.comLifeward to Report Fourth Quarter and Fiscal Year-End 2023 Financial Results on February 27, 2024February 15, 2024 | uk.investing.comRewalk Robotics Ltd (LFWD)February 15, 2024 | uk.investing.comRewalk Robotics Ltd (RWLK)February 13, 2024 | cnn.comReWalk Robotics Ltd.February 6, 2024 | finance.yahoo.com7 ‘AgeTech’ Stocks to Profit From the Booming Longevity MarketJanuary 31, 2024 | finanznachrichten.deReWalk Robotics Ltd. (DBA Lifeward): ReWalk Robotics Transforms Company Identity, Rebrands as LifewardJanuary 31, 2024 | msn.comRewalk Robotics Rebrands as Lifeward, Announces New TickerJanuary 15, 2024 | finance.yahoo.comReWalk Robotics (NASDAQ:RWLK investor five-year losses grow to 82% as the stock sheds US$10m this past weekJanuary 12, 2024 | finance.yahoo.comReWalk Robotics Expands Direct Sales Coverage to CanadaJanuary 11, 2024 | finance.yahoo.comReWalk Robotics Ltd. to Present at Sidoti Virtual Investor Conference on January 17January 5, 2024 | finanznachrichten.deReWalk Robotics Ltd.: First ReWalk Personal Exoskeleton Claim Paid by MedicareJanuary 5, 2024 | finance.yahoo.comFirst ReWalk Personal Exoskeleton Claim Paid by MedicareJanuary 4, 2024 | finance.yahoo.comReWalk Robotics CEO Issues Year-End 2023 Open Letter to Shareholders and Provides 2024 Commercial and Operational PrioritiesNovember 30, 2023 | finance.yahoo.comReWalk Robotics Presents on Personal Exoskeleton Pricing at Medicare Public MeetingNovember 28, 2023 | finanznachrichten.deReWalk Robotics Ltd.: ReWalk Robotics Demonstrates AI Autonomous Decision Making in Next Generation Exoskeleton PrototypeNovember 28, 2023 | finance.yahoo.comReWalk Robotics Demonstrates AI Autonomous Decision Making in Next Generation Exoskeleton PrototypeNovember 14, 2023 | finanznachrichten.deReWalk Robotics Ltd.: ReWalk Robotics Reports Third Quarter 2023 Financial ResultsSee More Headlines Receive RWLK Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ReWalk Robotics and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/11/2021Today3/27/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolNASDAQ:RWLK CUSIPN/A CIK1607962 Webwww.rewalk.com Phone(724) 959-0123FaxN/AEmployees56Year FoundedN/APrice Target and Rating Average Stock Price Target$3.00 High Stock Price Target$3.00 Low Stock Price Target$3.00 Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($0.37) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-19,570,000.00 Net Margins-238.35% Pretax Margin-233.51% Return on Equity-29.00% Return on Assets-25.27% Debt Debt-to-Equity RatioN/A Current Ratio3.47 Quick Ratio2.99 Sales & Book Value Annual Sales$5.51 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value$1.10 per share Price / BookN/AMiscellaneous Outstanding Shares60,030,000Free Float58,764,000Market Cap$63.04 million OptionableOptionable Beta2.30 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Lawrence J. Jasinski BS (Age 67)MBA, CEO & Director Comp: $654.03kMr. Michael A. Lawless (Age 56)Chief Financial Officer Comp: $110.24kMs. Miri Pariente (Age 47)Vice President of Operations, Regulatory & Quality Comp: $335.1kMs. Jeannine Lynch (Age 59)Vice President of Market Access & Strategy Comp: $425.98kMs. Kathleen O'DonnellVice President of Marketing & New Business DevelopmentMr. Charles RemsbergChief Sales OfficerMs. Judy KulaVice President of Customer Service, Human Resources & Business AffairsMore ExecutivesKey CompetitorsLeap TherapeuticsNASDAQ:LPTXIMACNASDAQ:IMACGBSNYSE:GBSFuture Health ESGNASDAQ:FHLTEnzo BiochemNYSE:ENZView All CompetitorsInsiders & InstitutionsKent Lake Capital LLCBought 683,447 shares on 2/14/2024Ownership: 1.139%Global Fund Lp Lind IIBought 5,031,200 shares on 9/26/2023Total: $3.52 M ($0.70/share)Global Fund Lp Lind IIBought 19,779 shares on 9/5/2023Total: $13,845.30 ($0.70/share)Global Fund Lp Lind IIBought 11,597 shares on 9/1/2023Total: $8,233.87 ($0.71/share)Joseph E Turk JrBought 2,661 shares on 9/1/2023Total: $1,809.48 ($0.68/share)View All Insider TransactionsView All Institutional Transactions RWLK Stock Analysis - Frequently Asked Questions Should I buy or sell ReWalk Robotics stock right now? 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for ReWalk Robotics in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" RWLK shares. View RWLK analyst ratings or view top-rated stocks. What is ReWalk Robotics' stock price target for 2024? 1 equities research analysts have issued 1-year price objectives for ReWalk Robotics' shares. Their RWLK share price targets range from $3.00 to $3.00. On average, they predict the company's stock price to reach $3.00 in the next twelve months. View analysts price targets for RWLK or view top-rated stocks among Wall Street analysts. How were ReWalk Robotics' earnings last quarter? ReWalk Robotics Ltd. (NASDAQ:RWLK) issued its quarterly earnings results on Thursday, November, 11th. The medical device company reported ($0.06) earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of ($0.06). The medical device company earned $1.97 million during the quarter, compared to the consensus estimate of $1.60 million. ReWalk Robotics had a negative net margin of 238.35% and a negative trailing twelve-month return on equity of 29.00%. During the same quarter last year, the business posted ($0.18) EPS. What other stocks do shareholders of ReWalk Robotics own? Based on aggregate information from My MarketBeat watchlists, some companies that other ReWalk Robotics investors own include Chembio Diagnostics (CEMI), Prospect Capital (PSEC), Calumet Specialty Products Partners (CLMT), Two Harbors Investment (TWO), BlackRock Capital Investment (BKCC), NovoCure (NVCR), Viper Energy (VNOM), Summit Midstream Partners (SMLP), Washington Prime Group (WPG) and Roper Technologies (ROP). Who are ReWalk Robotics' major shareholders? ReWalk Robotics' stock is owned by a variety of institutional and retail investors. Top institutional investors include Kent Lake Capital LLC (1.14%), Simplex Trading LLC (0.00%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Global Fund Lp Lind II, Jeannine Lynch, Jeff Dykan, Joseph E Turk Jr, Lawrence J Jasinski and Michael A Lawless. View institutional ownership trends. How do I buy shares of ReWalk Robotics? Shares of RWLK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:RWLK) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryThe 3rd Revolution in WarfareWeiss RatingsIs AI Energy Really 4 Million Times More Powerful Than Oil? (Surprising Answer)Banyan Hill Publishing“Cash Frenzy” to Hit Banks on March 20?Stansberry ResearchBill Ackman’s 2024 warningPorter & CompanyUrgent: Protect Your Investments from a Chinese InvasionBehind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ReWalk Robotics Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.